Robert A. Schoevers, MD, PhD

  • 8Articles
  • 51.1KReads
  • 2015–2022Active
  • 35Collaborators
  • 241Citations

About

Robert A. Schoevers, MD, PhD, is affiliated with the University of Groningen, University Medical Center Groningen, Department of Psychiatry, and the Research School of Behavioural and Cognitive Neurosciences (BCN) in Groningen, the Netherlands. Schoevers has contributed to Psychiatrist.com from 2015 to 2022, authoring eight articles focused on depression, anxiety, psychiatry, psychotic disorders, suicide, and patient care. Frequent collaborators include Brenda W. J. H. Penninx, Aartjan T. F. Beekman, Albert M. van Hemert, Jeanine Kamphuis, and Jolien K. E. Veraart.

Publications

JCP
Combined Ketamine and Monoamine Oxidase Inhibitors
Systematic Review

Combined Ketamine and Monoamine Oxidase Inhibitors

October 24, 2022

Little is known about actual side effects of augmentation of ketamine to monoamine oxidase inhibitors (MAOIs). This systematic review and cases series evaluated symptoms of serotonin syndrome and hypertension...
, , , et al
JCP
Systematic Review

Ketamine and Risk of Psychosis in Vulnerable Patients

July 13, 2021

Psychotic features are an exclusion criterion in most ketamine treatment studies given the assumption that ketamine use increases psychosis. This systematic review examined whether this assumption holds true in...
, , , et al
JCP
Original Research

Predicting Initial Specialist Care in Adolescence

July 10, 2018

Many adolescents with mental disorders do not receive specialist treatment, and those who do often wait several years before beginning treatment. Do parents, teachers, or the adolescents themselves have...
, , , et al
JCP
Original Research

Validity of the Maudsley Staging Method in Predicting Depression Outcome

January 23, 2018

The Maudsley Staging Method has been validated as a way to quantify and predict depression course and outcome, but its generalizability to a community-based population had not yet been...
, , , et al
JCP
Original Research

Anxious Distress as Predictor of MDD Outcome

February 22, 2017

DSM-5 includes a new tool for assessing anxiety in depression. Read this article to find out how the anxious distress specifier performs as a predictor of major depressive disorder...
, , , et al
JCP
Original Research

Offspring of Depressed and Anxious Patients

January 25, 2017

Environmental and genetic risk factors influence whether a person will develop depression as well as what the prognosis will be. This study looked at illness incidence over 10 years...
, , , et al
JCP
Letter to the Editor

Reduction in Suicidal Ideation Following Repeated Doses of Intravenous Ketamine?

January 25, 2017

, ,
JCP
Original Research

Clinical Staging of Major Depressive Disorder: An Empirical Exploration

September 23, 2015

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe